EN ISO 14708-6:2022 PDF

Overview

EN ISO 14708-6:2022 (identical to ISO 14708-6:2019) is a CEN-adopted standard that defines particular requirements for active implantable medical devices intended to treat tachyarrhythmia, including implantable cardioverter‑defibrillators (ICDs) and CRT‑D systems. It sets out design, testing and documentation requirements for implantable pulse generators, leads (endocardial and epicardial) and some associated non‑implantable parts and accessories that could affect device safety or performance. The standard specifies type tests to be carried out on device samples to demonstrate compliance and recognizes the emergence of leadless or alternative technologies that may require manufacturer-led adaptations.

Key topics and technical requirements

• Scope and applicability: Requirements apply to antitachyarrhythmia functions of ICDs/CRT‑Ds; bradyarrhythmia and resynchronization aspects are covered by ISO 14708-2.
• Type testing and measurements: Standardized methods for measuring implantable pulse generator and lead characteristics (output voltage, delivered pulse energy, antitachyarrhythmia pacing, sensitivity, charge time, capacitor maintenance). Manufacturers may use equivalent methods if demonstrated at least as accurate; the standard’s method prevails in disputes.
• Device construction, packaging and markings: Requirements for sales packaging, sterile packs, non‑reusable packs and device labelling to ensure safe handling and traceability.
• Electrical, thermal and radiation protection: Protection from harm to patient and user due to electricity, heat, ionizing and non‑ionizing radiation, and from unintended biological effects.
• Electromagnetic and external influences: Protection against interference from external defibrillators, high‑power electrical fields, atmospheric/temperature changes, electrostatic discharge and miscellaneous medical treatments.
• Software, data security and usability: Requirements for non‑implantable software elements, usability of external parts and protection from unauthorized information tampering.
• Risk management and documentation: Clauses on general risk management, accompanying documentation, and testing records; informative annexes map principles and provide nomenclature guidance.

Practical applications and users

Who uses EN ISO 14708-6:2022:

• Medical device manufacturers (ICD/CRT‑D designers) for design verification, type testing and technical files.
• Independent testing laboratories and notified bodies for conformity assessment and type test execution.
• Regulatory and quality teams for compliance with European and international requirements.
• Clinical engineers and hospitals for understanding device labelling, packaging and safety characteristics.
• Procurement and risk‑management professionals evaluating device performance and interoperability.

Related standards

• ISO 14708 series (other parts for bradyarrhythmia/resynchronization) - see ISO 14708-2.
• Nomenclature references such as ISO 14117 and informative guidance like ISO/TR 14283 are cross‑referenced within the document.

Keywords: EN ISO 14708-6:2022, implantable defibrillators, active implantable medical devices, ICD, CRT‑D, tachyarrhythmia, type tests, device testing, medical device standards.